Francesco Porpiglia

Medi-Tate Ltd. operates as a medical device company. It develops implantable medical devices for the treatment of benign prostate hyperplasia. The firm's product TIND, which designs to alleviate benign prostatic hyperplasia (BPH) symptoms. The company was founded by Ido Kilemnik in 2007 and is headquartered in Or Akiva, Israel.

Medi-Tate Ltd. operates as a medical device company. It develops implantable medical devices for the treatment of benign prostate hyperplasia. The firm's product TIND, which designs to alleviate benign prostatic hyperplasia (BPH) symptoms. The company was founded by Ido Kilemnik in 2007 and is headquartered in Or Akiva, Israel.

Medi-Tate Ltd. operates as a medical device company. It develops implantable medical devices for the treatment of benign prostate hyperplasia. The firm's product TIND, which designs to alleviate benign prostatic hyperplasia (BPH) symptoms. The company was founded by Ido Kilemnik in 2007 and is headquartered in Or Akiva, Israel.

Medi-Tate Ltd. operates as a medical device company. It develops implantable medical devices for the treatment of benign prostate hyperplasia. The firm's product TIND, which designs to alleviate benign prostatic hyperplasia (BPH) symptoms. The company was founded by Ido Kilemnik in 2007 and is headquartered in Or Akiva, Israel.

Medi-Tate Ltd. operates as a medical device company. It develops implantable medical devices for the treatment of benign prostate hyperplasia. The firm's product TIND, which designs to alleviate benign prostatic hyperplasia (BPH) symptoms. The company was founded by Ido Kilemnik in 2007 and is headquartered in Or Akiva, Israel.